Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Cognitive & Nootropic Peptide Reference

Peptides that target cognitive function through neurotrophic, neuroprotective, or neuromodulatory mechanisms — from synthetic ACTH analogs (Semax) to multi-peptide brain extracts (Cerebrolysin) and experimental cognitive enhancers (Dihexa).

Cognitive & Nootropic Peptides (6)

Frequently Asked Questions

Which nootropic peptide has the best evidence?
Cerebrolysin has the largest human trial datasets (CASTA, CERE-LYSE) in stroke and vascular dementia. Semax has the widest clinical use history (decades of Russian prescribing). Dihexa has the most preliminary evidence — potent in vitro but no human trial data.
Why are most cognitive peptides administered intranasally?
Two reasons: peptides have near-zero oral bioavailability (GI proteases destroy them), and the nasal mucosa provides both systemic absorption (bypassing first-pass liver metabolism) and potential direct CNS access via olfactory nerve pathways. Intranasal delivery is the practical route for peptides targeting the brain.
How do nootropic peptides differ from traditional nootropics like racetams?
Peptide nootropics (Semax, Selank) primarily work through neurotrophic factor upregulation (BDNF, NGF) — promoting long-term neuroplasticity. Racetams modulate acetylcholine and glutamate receptors for acute cognitive effects. Peptides tend to have subtler, more gradual effects but may promote structural brain changes over time.
Can cognitive peptides help with ADHD?
Semax has been used clinically in Russia for ADHD-adjacent indications, with reported improvements in attention and executive function. No Western clinical trial has evaluated Semax for ADHD. The dopamine-modulating mechanism is theoretically relevant, but evidence-based ADHD treatment in Western medicine relies on stimulants and behavioral therapy.

Related Product Categories

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.